DOCSLIB.ORG

ED331394.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ED331394.Pdf DOCUMENT RESUME ED 331 394 HE 024 451 TITLE Substance Abuse Curriculum Development in Family Medicine: An Instructors' Manual in Two Parts. INSTITUTION Society for Teachers of Family Medicine, Kansas City, MO SPONS AGENCY National Inst. on Alcohol Abuse and Alcoholism (DHHS), Rockville, Md.; National Inst. on Drug Abuse (DHHS/PHS), Rockville, Md. REPORT NO PH275 PUB DATE 89 CONTRACT ADM-281-87-0002 NOTE 102p.; For relateC documents, see HE 024 447-452 PUB TYPE Guides - Non-Classroom Use (055) EDRS PRICE mFo1/Pc05 Plus Postage. DESCRIPTORS *Curriculum Development; Faculty Development; *Family Practice (Medicine); Higher Education; *Institutes (Training Programs); *Medical Education; Program Evaluation; *Substance Abuse ABSTRACT This -nstructor's manual is a practical guide to a faculty development taining program on substance abuse within family medicine emphasizing a meshing of individual curriculum projects by participants with group instruction and support. Organized into two parts the manual describes the training program in detail in Part 1 and provides 10 actual curriculum examples in Part 2. The training program description includes a section on how to use the manual, an exposition of the program's philosophy, suggestions for evaluation, a list of the faculty resources materials and fac:ilities needed to run the program, suggestions for adapting the program, and practical hints for a successful program. The curriculum examples in Part Two are grouped according to educational level including undergraduate (e.g., improving early diagnosis of substance abuse by medical students), residency (e.g., the impaired health professional), faculty (e.g., a curriculum in substance abuse for family practice faculty), and two applicable to all levels (e.g., how to stay sober and serene in dealing with alcoholic patients). Eych curriculum is outlined listing such elements as rationale, objectives, activity sequences, instructional resourCes, evaluation strategies, hints to the instructor, and an appendix of key materials 35) **************************************** ****** ********* ***** *********** Reproductions supplied by EDRS are the best that can be made 4 from the original document. *********************************************************************** SUBSTANCEABUSE CURRICULUMDEVELOPMENT IN FAMILYMEDICINE: AN INSTRUCTORS'MANUAL IN TWOPARTS !).EST COPY AVAILABLE U S DEPARTMENT Of EDUCATJON '. (Ito Mona, Rmwar, n and F ()II( ATIONAt E S)uRCES ORMAT,c CE NTF E Hs( r s 1 P OPP, fr.1.,,m),,, Oilat 0,,N1 pefsc, .tkcj,niong harups ha,p ,Woduf 1,or 1441, S. 41,114°0 It, 4.5%41,,,r The Society of Teachersof Family Medicine MO Ward Parkway Kansas City, Missouri64114 Based on work supported throughcontract #ADM 281-87-0002 from the National InstituMon Alcohol Abuse and Alcoholian and the National Institute on Drug Abuse P11275 um STFM PROGRAM PEOPLE PARTICIPANTS: WORKING COMMITTEE: Richard L. Brown, MD, MPH Anton J. Kurel, MD Jeffersen Medical College Department Faro Practice Director 1015 Walnut St., Suite 401 Medical College of Virginia Peter G. Coggan, MD Philadelphia, PA 19107 Fairfax Family Practice Center Department of Family Medicine (215).928-8363 3650 Joseph Siewick Dr.400 University of California - Irvine Fairfax, VA 22033 101 The City Drive South Lorne Campbell. Sr.. MD (703) 391-2020 Orange, CA 92668 Serenity Recovery Center (714) 634-5171 232 W. 25 St. Jerome Schulz. MD Erie, PA 16544 Family Practice Residency Train- Co-Director (814) 452-5556 ing Pfinram Rebecca Henry, PhD St. Paul-Ramsey Medical Center Office of Medical Education Research and Development James N. Finch, MD 640 Jackson St. Michigan State University Duke University Medical Center St. Paul, MN 55101 A 202 East Fee Hall Department Comm/Family (612) 221-3540 East Lansing. MI 48824 Medicine (517) 353-2037 407 Crutchfield St. J. Paul Seale, MD Durham, NC 27704 Dept. of Family Practice Coordinator (919) 471-4421 Ext. 223 University of Texas Health Sci. Ardis Davis, MSW ence Center Department of Family Medicine RF-30 Michael F Fleming. MD. MPH 7703 Floyd Curl Drive University of Washington School of Medicine Department of Family Medicthe San Antonio, TX 78284 Sunk, WA 98195 University of Wisconsin (512) 270-3911 (206) 543-9425 777 South Mill Si. Madison, WI 53715 Administrator (608) 263-9953 Roger A. Sherwood, CAE Society of ibachers of Family Medicine Stephen P Flynn. MD 8880 Ward Parkway Family Practice Center PO Box 8729 Fairview General Hospital Kansas City, MO 64114 18200 Lorain Ave. (800) 274-2237 Cleveland, OH 44111 (216) 476-7086 Advbory Members Macaran A. Baird, MD, MS Robert H. Funke. MD Deportment of Family Medicine Kingsport Family Practice Center SUNY Health Science Center 201 Cassell Drive 750 E. Adams Street Kingsport, TN 37660 Syracuse. NY 13210 (615) 246-6202 (315) 473-4437 Benjamin Goodman. Jr., MD Antonnette V. Graham, RN, MSW Medical Am Clinic University Hospitals Health Center 24 Second Ave. NE Case Western Reserve University Hickory, NC 28601 Department of Family Medicine (704) 328-2231 2078 Abington Road Cleveland, OH 44106 (216)844-3791 Al J. Mooney, MD 311 Jones Mill Rd. Statesboro, GA 30458 (912) 764-6236 CONSULTANTS: ACKNOWLEDGEMENTS Carole J. Bland, PhD Sincere thanks and appreciatimi are mended to the staff of theSociety of Department of Family Practice and Community Health Teachers of Family Medicine whose work assured the smoothrunning of 6-240 Phillips Wangensteen Bldg. the program. Of particular note is Chris Malang. whospearheaded the 516 Delaware St. SE innunseable circulations of materials, and Julie Mierau, whocoordinated Box 381 UMHC the editing and typesetting. Minneapolis, MN 55455 (612) 624-9143 Raymond C. Anderson. MD Anns Acres PO Boa X Cannel, NY 10512 TABLE OF CONTENTS Part I Page LIST OF APPENDICES AND FIGURES FOR PART I ...2 INTRODUCTION 3 HOW TO USE THIS MANUAL 3 Replication of Entire Program Modified Version of Program Replication of Selected Elements of Program Specific Curriculum Examples in Substance Abuse Practical Advice on Tough Curriculum Issues UNDERLYING PHILOSOPHY OF TRAINING PROGRAM 4 THE TRAINING PROGRAM 4 Overview Working Committee Program Objectives Participant Characteristics and Selection Process Program Implementation EVALUATION OF THE TRAINING PROGRAM 9 FACULTY, RESOURCES, MATERIALS AND FACILITIES NECESSARY TO RUN THE PROGRAM I I Resources Materials Facilities ADAPTING THE TRAINING PROGRAM I I FURTHER HINTS FOR A SUCCESSFUL PROGRAM 12 REFERENCES 12 Part II SUMMAICY OF CURRICULUM EXAMPLES 19 PRACTICAL ADVICE ON TOUGH CURRICULUM ISSUES 19 TEN CURRICULUM EXAMPLES (grouped by educational level of learners) UNDERGRADUATE Funke, Robert H. "Promoting Medical Student Recognition of Chemical Dependency" 21 Brown, Richard L. "improving Early Diagnosis of Substance Abuw by Medical Students" 27 RESIDENCY Flynn, Stephen P. 33 "Alcoholism: Diagnosis and Inteivention for Family Physicians" Goodman, Benjamin W. Jr. 43 "The Impaired Health Professional: A Curriculum for PGY-I Residents" Seale, I. Paul 53 "Planning and Implementing a Pan-Time PG-I Resident Rotation in Substance Abuse" Campbell, Lorne It Sr. 65 "A One-Week Packaged Flexible Module for Family Practice Residents" FACULTY Finch, James 75 "A Curriculum in Substance Abuse for Family Practice Faculty" Kum!, Anton J. 85 "A Brief Intervention Strategy for Faculty Development in Chemical Dependency Syndrome" ALL LEVELS Schulz, Jerome E 93 "How to Stay Sober and Serene in Dealing with Alcohvlic Patients" Fleming, Michael F 101 "Alcohol and Drug Withdrawal: Medical Management" Substance Abuse Curriculum Development in Family Medicine PART I: A FACULTY DEVELOPMENT TRAINING PROGRAMIN SUBSTANCE ABUSE LIST OF FIGURES ANDAPPENDICES FOR PART I Page LIST OF FIGURES Figure 1. Overview of Training Program 4 figure 2. Objectives of 'Raining Program 5 figure 3. Instructional Elements of Training Program 6 Figure 4. Training Program Objectives Met Through Instructional Elements 7 figure 5. Working Cominee (WC) Activities 8 Figure 6. Participants' Activities 9 Figure 7. Program Objectives Assessed Through Evaluation Elements 9 Figure 8. Specific Evaluation Strategies and Outcome Measures 10 APPENDICES A. Sample Format for Final Curriculum 13 Project Write-Ups B. Sample Activity Sequence for Group 14 Instructional Meeting #1 C. Willingway Hospital 15 D. References for Learning Materials and 15 Tbaching Resources INTRODUCTION This manual was developed through a federal contract to the Society of Teachers of Family Modiciee (STFM), the purpose of which was to increasing faculty development activities at the individual home institu- demonstrate a model substance erre faculty development training tions of participants. Moreover, it enables participants to describe their program in family medicine. It was developed from a combinatioe of curriculum development vvork in a scholarly manner, the end product of this being separate curriculum .1xamples bound into a manual for use by what worked well in STFM's initial experience with the training program in conitination with suggested changes to enhance the success of future each other and by educators elsewhere . programs based on the underlying model. A description of the STFM pilot test of this model training ptogram can be found in a separate The major characteristics of the training program are a meshing of document submitted as one of the final repom to the National Institute cm individual curriculum projects by participants with group instruction and Alcohol Abuse and Alcoholism and the National Institute on Drug support to
Load more

Recommended publications
  • The Hematological Complications of Alcoholism
    The Hematological Complications of Alcoholism HAROLD S. BALLARD, M.D. Alcohol has numerous adverse effects on the various types of blood cells and their functions. For example, heavy alcohol consumption can cause generalized suppression of blood cell production and the production of structurally abnormal blood cell precursors that cannot mature into functional cells. Alcoholics frequently have defective red blood cells that are destroyed prematurely, possibly resulting in anemia. Alcohol also interferes with the production and function of white blood cells, especially those that defend the body against invading bacteria. Consequently, alcoholics frequently suffer from bacterial infections. Finally, alcohol adversely affects the platelets and other components of the blood-clotting system. Heavy alcohol consumption thus may increase the drinker’s risk of suffering a stroke. KEY WORDS: adverse drug effect; AODE (alcohol and other drug effects); blood function; cell growth and differentiation; erythrocytes; leukocytes; platelets; plasma proteins; bone marrow; anemia; blood coagulation; thrombocytopenia; fibrinolysis; macrophage; monocyte; stroke; bacterial disease; literature review eople who abuse alcohol1 are at both direct and indirect. The direct in the number and function of WBC’s risk for numerous alcohol-related consequences of excessive alcohol increases the drinker’s risk of serious Pmedical complications, includ- consumption include toxic effects on infection, and impaired platelet produc- ing those affecting the blood (i.e., the the bone marrow; the blood cell pre- tion and function interfere with blood cursors; and the mature red blood blood cells as well as proteins present clotting, leading to symptoms ranging in the blood plasma) and the bone cells (RBC’s), white blood cells from a simple nosebleed to bleeding in marrow, where the blood cells are (WBC’s), and platelets.
    [Show full text]
  • Vol. 81 Friday, No. 73 April 15, 2016 Pages 22173–22510
    Vol. 81 Friday, No. 73 April 15, 2016 Pages 22173–22510 OFFICE OF THE FEDERAL REGISTER VerDate Sep 11 2014 19:00 Apr 14, 2016 Jkt 238001 PO 00000 Frm 00001 Fmt 4710 Sfmt 4710 E:\FR\FM\15APWS.LOC 15APWS mstockstill on DSK4VPTVN1PROD with FEDWS II Federal Register / Vol. 81, No. 73 / Friday, April 15, 2016 The FEDERAL REGISTER (ISSN 0097–6326) is published daily, SUBSCRIPTIONS AND COPIES Monday through Friday, except official holidays, by the Office PUBLIC of the Federal Register, National Archives and Records Administration, Washington, DC 20408, under the Federal Register Subscriptions: Act (44 U.S.C. Ch. 15) and the regulations of the Administrative Paper or fiche 202–512–1800 Committee of the Federal Register (1 CFR Ch. I). The Assistance with public subscriptions 202–512–1806 Superintendent of Documents, U.S. Government Publishing Office, Washington, DC 20402 is the exclusive distributor of the official General online information 202–512–1530; 1–888–293–6498 edition. Periodicals postage is paid at Washington, DC. Single copies/back copies: The FEDERAL REGISTER provides a uniform system for making Paper or fiche 202–512–1800 available to the public regulations and legal notices issued by Assistance with public single copies 1–866–512–1800 Federal agencies. These include Presidential proclamations and (Toll-Free) Executive Orders, Federal agency documents having general FEDERAL AGENCIES applicability and legal effect, documents required to be published Subscriptions: by act of Congress, and other Federal agency documents of public interest. Assistance with Federal agency subscriptions: Documents are on file for public inspection in the Office of the Email [email protected] Federal Register the day before they are published, unless the Phone 202–741–6000 issuing agency requests earlier filing.
    [Show full text]
  • Personal Habits and Indoor Combustions Volume 100 E a Review of Human Carcinogens
    PERSONAL HABITS AND INDOOR COMBUSTIONS volume 100 e A review of humAn cArcinogens This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 29 September-6 October 2009 LYON, FRANCE - 2012 iArc monogrAphs on the evAluAtion of cArcinogenic risks to humAns CONSUMPTION OF ALCOHOLIC BEVERAGES Consumption of alcoholic beverages was considered by previous IARC Working Groups in 1987 and 2007 (IARC, 1988, 2010). Since that time, new data have become available, these have been incorporated into the Monograph, and taken into consideration in the present evaluation. 1. Exposure Data fruit, vegetables or parts of palm trees, by a fairly simple production process. 1.1 Types and ethanol content of 1.1.2 Ethanol content of alcoholic beverages alcoholic beverages Percentage by volume (% vol) is used to indi­ 1.1.1 Types of alcoholic beverages cate the ethanol content of beverages, which is The predominant types of commercially also called the French or Gay-Lussac system. produced alcoholic beverages are beer, wine and Alcohol content differs according to the main spirits. Basic ingredients for beer are malted beverage type and may also vary by country. barley, water, hops and yeast. Wheat may be Commonly, 4–5% vol are contained in beer, used. Nearly all wine is produced from grapes, about 12% vol in wine and about 40% vol in although wine can be also made from other fruits distilled spirits. However, lower or higher ethanol and berries. Spirits are frequently produced from content in alcoholic beverages is also possible.
    [Show full text]
  • Alcoholic Liver Disease Your Role Is Essential in Preventing, Detecting, and Co-Managing Alcoholic Liver Disease in Inpatient and Ambulatory Settings
    Preventing drinking relapse in patients with alcoholic liver disease Your role is essential in preventing, detecting, and co-managing alcoholic liver disease in inpatient and ambulatory settings Gerald Scott Winder, MD lcohol use disorder (AUD) is a mosaic of psychiatric and Assistant Professor medical symptoms. Alcoholic liver disease (ALD) in its acute Department of Psychiatry University of Michigan Health System and chronic forms is a common clinical consequence of long- Ann Arbor, Michigan A standing AUD. Patients with ALD require specialized care from pro- Jessica Mellinger, MD, MSc fessionals in addiction, gastroenterology, and psychiatry. However, Clinical Lecturer medical specialists treating ALD might not regularly consider medi- Department of Internal Medicine University of Michigan Health System cations to treat AUD because of their limited experience with the Ann Arbor, Michigan drugs or the lack of studies in patients with significant liver disease.1 Robert J. Fontana, MD Similarly, psychiatrists might be reticent to prescribe medications for Professor of Medicine AUD, fearing that liver disease will be made worse or that they will Division of Gastroenterology cause other medical complications. As a result, patients with ALD Department of Internal Medicine University of Michigan Health System might not receive care that could help treat their AUD (Box, page 24). Ann Arbor, Michigan Given the high worldwide prevalence and morbidity of ALD,2 gen- Disclosures eral and subspecialized psychiatrists routinely evaluate patients with Dr. Winder and Dr. Mellinger report no financial AUD in and out of the hospital. This article aims to equip a psychia- relationships with any company whose products are mentioned in this article or with manufacturers of trist with: competing products.
    [Show full text]
  • A004 - ADULT PATIENTS with MACROCYTOSIS Most Causes of Macrocytosis Are Not Due to Haematological Diseases
    Haematology A004 - ADULT PATIENTS WITH MACROCYTOSIS Most causes of macrocytosis are not due to haematological diseases. Macrocytosis may be found as an isolated abnormality or be associated with anaemia, thrombocytopenia or other changes in the blood count. A blood film is frequently performed in patients with macrocytosis to look for signs of haematological disease – further advice may have been given by haematologist as a film comment. What causes should I consider? Alcoholism (the commonest cause of macrocytosis in the UK) or other occult liver disease (often in association with thrombocytopenia). Vitamin B12 or folate deficiency (may cause pancytopenia if severe). Drugs which interfere with DNA synthesis (including azathioprine, methotrexate, hydroxycarbamide, some HAART drugs). Pregnancy (physiological change). Haemolytic anaemia (reticulocytosis), especially if jaundiced. Hypothyroidism Smoking (Hb may be higher than normal). Rare haematological causes include myelodysplasia, aplastic anaemia. Idiopathic – some patients have MCVs out with normal range but no underlying abnormality. What should I look for? History – diet, alcohol, drugs, FH pernicious anaemia/autoimmune diseases, history of bowel surgery, artificial valves… Examination – anaemia, jaundice, glossitis, splenomegaly (seen with haemolysis, liver disease or myelodysplasia), neurological signs. What investigations may be useful? FBC - check blood film comment (may detect megaloblastic change, MDS, haemolysis or signs suspicious of marrow infiltration). Vitamin B12 and folate levels - if B12/folate deficiency expected start replacement therapy whilst awaiting results. TFTs LFTs (bilirubin raised in haemolysis; may detect occult liver disease). Reticulocyte count and Direct Antiglobulin Test (DAT aka. Coomb’s) may be requested by lab if haemolysis suspected on blood film. When should I seek further advice or refer to haematology? B12 and/or folate deficiency – discuss with gastroenterology.
    [Show full text]
  • Pharmacotherapy for Alcohol Use Disorders
    Pharmacotherapy for Alcohol Use Disorder Larissa Mooney, MD Associate Professor of Psychiatry UCLA Integrated Substance Abuse Programs 1 Larissa Mooney Disclosures • Dr. Larissa Mooney has no financial relationships to disclose. The contents of this activity may include discussion of off label or investigative drug uses. The faculty is aware that is their responsibility to disclose this information. 2 Target Audience • The overarching goal of PCSS-MAT is to make available the most effective medication-assisted treatments to serve patients in a variety of settings, including primary care, psychiatric care, and pain management settings. 3 Educational Objectives • At the conclusion of this activity participants should be able to: . Summarize mechanisms of action for three approved medications for alcohol use disorder treatment . Describe common adverse effects of approved medications for alcohol use disorder . Report dosing regimens for alcohol use disorder medications 4 Outline • Establishing alcohol use disorder (AUD) diagnosis • Rationale for use of pharmacotherapy for alcohol use disorder • Dosing, mechanism of action, and adverse effects for FDA approved medications for AUD . Disulfiram . Acamprosate . Naltrexone • Evidence-based but off-label medication options for AUD: gabapentin and topiramate • Case vignette: AUD pharmacotherapy options 5 AUD Meds are Underutilized • Alcohol use disorder (AUD) is one of only 3 substance use disorders with FDA approved medications (tobacco, opioids, alcohol) • Also have some efficacious non-approved pharmacotherapy options • 17 million US adults have an AUD • Yet very little use of AUD medications • Fewer than 1 in 10 individuals treated for AUD receive medications (NSDUH 2013) 6 NIAAA 2014, NIH Publication No. 14-7974) Context for Use of Pharmacotherapy • Addiction is a chronic, relapsing brain disease characterized by compulsive use despite harmful consequences • Medications may be used as a tool within a comprehensive treatment plan: .
    [Show full text]
  • Assessment and Treatment of Alcohol Dependence Suggested Citation: Quigley, A., Connolly, C., Palmer, B., & Helfgott, S
    A brief guide to the Assessment and Treatment of Alcohol Dependence Suggested citation: Quigley, A., Connolly, C., Palmer, B., & Helfgott, S. (2015) A brief guide to the assessment and treatment of alcohol dependence (2nd ed.). Perth, Western Australia: Drug and Alcohol Office. ISBN: 978-1-876684-63-1 © Western Australian Drug and Alcohol Authority 2015 Note – The Drug and Alcohol Office is the business name of the Western Australian Alcohol and Drug Authority, which is an independent statutory authority established in November 1974. Its functions are set out in the Alcohol and Drug Authority Act 1974. This booklet is produced by Next Step Drug and Alcohol Services and Workforce Development Branch, Drug and Alcohol Office. It may be reproduced in whole or in part for study or training purposes subject to an inclusion of an acknowledgement of the source and no commercial usage or sale. Reproduction for purposes other than those above requires the written permission of: Drug and Alcohol Office, PO Box 126, Mount Lawley WA 6929 Website: www.dao.health.wa.gov.au Next Step DRUG AND ALCOHOL SERVICES ii A brief guide to the Assessment and Treatment of Alcohol Dependence Contents Introduction ................................................................................................................................................................2 Assessment .................................................................................................................................................................2 History .........................................................................................................................................................................2
    [Show full text]
  • Evaluation of Macrocytosis JOYCE KAFERLE, MD, and CHERYL E
    Evaluation of Macrocytosis JOYCE KAFERLE, MD, and CHERYL E. STRZODA, MD, University of Michigan, Ann Arbor, Michigan Macrocytosis, generally defined as a mean corpuscular volume greater than 100 fL, is fre- quently encountered when a complete blood count is performed. The most common etiolo- gies are alcoholism, vitamin B12 and folate deficiencies, and medications. History and physical examination, vitamin B12 level, reticulocyte count, and a peripheral smear are helpful in delin- eating the underlying cause of macrocytosis. When the peripheral smear indicates megaloblas- tic anemia (demonstrated by macro-ovalocytes and hypersegmented neutrophils), vitamin B12 or folate deficiency is the most likely cause. When the peripheral smear is nonmegaloblastic, the reticulocyte count helps differentiate between drug or alcohol toxicity and hemolysis or hemor- rhage. Of other possible etiologies, hypothyroidism, liver disease, and primary bone marrow dysplasias (including myelodysplasia and myeloproliferative disorders) are some of the more common causes. (Am Fam Physician. 2009;79(3):203-208. Copyright © 2009 American Acad- emy of Family Physicians.) acrocytosis, defined as a approximately one fourth of these remain- mean corpuscular volume ing patients.1 In recent years, an association greater than 100 fL, occurs has been found between Helicobacter pylori 7 in approximately 3 percent infection and vitamin B12 deficiency. M of the general population.1 Debate persists about the upper limit of normal values Pathophysiology of mean corpuscular volume.
    [Show full text]
  • Alcoholism and Clinical Psychiatry Alcoholism and Clinical Psychiatry
    Alcoholism and Clinical Psychiatry Alcoholism and Clinical Psychiatry Edited by Joel Solomon Downstate Medical Center Brooklyn, New YorK Plenum Medical Book Company New York and London Library of Congress Cataloging in Publication Data Main entry under title: Alcoholism and clinical psychiatry. Bibliography: p. Includes index. 1. Alcoholism-Addresses, essays, lectures. 2. Psychiatry-Addresses, essays, lectures. 3. Psychology, Pathological-Addresses, essays, lectures. I. Solomon, Joel. (DNLM: 1. Alcoholism-Complications. 2. Alcoholism-Therapy. 3. Mental disorders - Complications. WM 274 A3S48] RC56S.A44S33 616.86'1 81-22701 ISBN-13: 978-1-4684-4030-0 e-ISBN-13: 978-1-4684-4028-7 AACR2 001: 10.1007/978-1-4684-4028-7 © 1982 Plenum Publishing Corporation Softcover reprint of the hardcover 1st edition 1982 233 Spring Street, New York, N.Y. 10013 Plenum Medical Book Company is an imprint of Plenum Publishing Corporation All rights reserved No part of this book may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise, without written permission from the Publisher Contributors Malcolm Beaudett, BS Third-Year Medical Student, State University of New York, Downstate Medical Center, Brooklyn, New York Sheila B. Blume, MD Director, New York State Division of Alcoholism and Alcohol Abuse, Clinical Associate Professor, Department of Psychi­ atry, Albany Medical College, Albany, New York Marc Galanter, MD Director, Division of Alcoholism and Drug Abuse, Associate Professor, Department of Psychiatry, Albert Einstein College of Medicine, Bronx, New York Donald M. Gallant, MD Professor, Department of Psychiatry, Adjunct Professor of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana Donald W.
    [Show full text]
  • Haematological Changes in Alcohol and Substance Use Dis- Orders- an Overview Raka Jain*, Aishwariya Brigit George and Shubham Narnoli
    ISSN: 2690-263X Jain et al. Int Arch Subst Abuse Rehabil 2020, 2:006 DOI: 10.23937/2690-263X/1710006 International Archives of Volume 2 | Issue 1 Open Access Substance Abuse and Rehabilitation MINI REVIEW Haematological Changes in Alcohol and Substance Use Dis- orders- An Overview Raka Jain*, Aishwariya Brigit George and Shubham Narnoli Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, India *Corresponding author: Dr. Raka Jain, Professor, Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi-110029, India, Tel: +91-11- Check for 26593595, Fax: +91-11-26588641 updates to the nervous system and internal organs. Moreover, Abstract illicit drug uses are commonly linked with aplastic anae- Alcohol and Substance use remains a worldwide social mia, bone marrow repression and variety of systemic problem. There is an increasing awareness that alcohol- ics and substance abusers do show some haematological disorders [3]. Hence, early diagnosis of these disorders abnormalities (e.g., hemoglobin, white blood cells count, and identification of the complications they result in is mean corpuscular volume, mean corpuscular haemoglobin important. Haematology is the branch of medicine that concentration, red blood cells count, hematocrit). Conse- deals with blood, blood-forming organs and blood dis- quences of these haematological abnormalities can result in serious medical complications. The aim of this paper is to orders. This article summarizes current information on present an overview of haematological changes in alcohol the haematological changes that are observed in dif- and substance use disorders. This may be beneficial for de- ferent substance use disorders and the utility of these fining the homeostasis condition of the body, which leads to changes in clinical assessment.
    [Show full text]
  • Pancytopenia and Folate Deficiency in Alcoholics
    Postgraduate Medical Journal (1987) 63, 117-120 Postgrad Med J: first published as 10.1136/pgmj.63.736.117 on 1 February 1987. Downloaded from Pancytopenia and folate deficiency in alcoholics Clive F.M. Weston and Michael J. Hall Department ofMedicine, Bristol Royal Infirmary, Bristol BS2 8HW, UK. Summary: Three alcoholic patients are reported who presented with pancytopenia and macrocytosis due to acute folate deficiency. While folate deficiency is a common finding in alcohol abusers due to abnormalities in diet, intestinal absorption, internal metabolism and excretion, this life-threatening complication has not been well documented. Introduction A low serum or red cell folate is a frequent finding in between 40 and 80 mg/I. Plasma urea was 1.3 mmol/l, chronic alcoholics who may or may not have sodium 138 mmol/l, potassium 2.8 mmol/I and levels megaloblastic anaemia. Although pancytopenia due of serum liver enzymes, calcium and phosphate were to folate deficiency has been reported as a complica- normal. Serum ferritin was greater than 500 (normal tion ofintravenous nutrition and haemodialysis it has range 15-99) ng/ml, vitamin B12 377 (normal range not been well documented in alcoholics with liver 150- 800) ng/I but the red cell folate was unrecordable. Protected by copyright. disease. We report the cases ofthree patients who were The bone marrow was megalobastic. admitted within an 18 month period with severe The patient was resuscitated with broad-spectrum pancytopenia and low or undetectable red cell folate antibiotics, transfusions of blood, platelets and fresh levels. Two of the patients were known alcoholics and frozen plasma, potassium supplements, vitamin B12 the other, who initially denied alcohol ingestion, was injections and oral folic acid, and by the seventh day of later readmitted with alcoholic hepatitis.
    [Show full text]
  • Rare Forms of Dementia
    Rare forms of dementia Final report of a project supported by the Community Rare Diseases Programme 2000-2002 Alzheimer Europe, Route de Thionville 145, L-2311 Luxembourg Rare forms of dementia General Introduction Final report of a project supported by the Community Rare Diseases Programme 2000-2002 This project received financial support from the Commission of the European Communities. The report was produced by a contractor for the Health & Consumer Protection Directorate-General and represents the views of the contractor or author. These views have not been adopted or in any way approved by the Commission and do not necessarily represent the view of the Commission or the Directorate-General for Health and Consumer Protection. The European Commission does not guarantee the accuracy of the data included in this project, nor does it accept responsibility for any use made thereof. Neither the European Commission nor any person acting on its behalf is responsible for any use that might be made of the following information. © European Communities, 2005 Reproduction is authorised, except for commercial purposes, provided the source is acknowledged. Printed by the services of the European Commission, Luxembourg Alzheimer Europe Rare Forms of Dementia Project Table of contents PREFACE 4 INTRODUCTION 8 DEMENTIA – DEFINITION - CONCEPT 12 EXPLANATION OF BRAIN 16 DIAGNOSTIC PROCEDURES 18 CARE AND TREATMENT 27 3 Alzheimer Europe Rare Forms of Dementia Project Preface By Jean GEORGES This report presents the results of the Alzheimer Europe project “Rare forms of dementia” which was financed in the framework of the rare diseases programme of the European Commission. Rare diseases are described by the European Community Action programme as diseases of low prevalence “which is generally recognised as less than 5 per 10,000 in the Community”.
    [Show full text]